|
HSPA4L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.015490E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.037700E-04 |
| Normal-vs-Stage2 |
9.843000E-01 |
| Normal-vs-Stage3 |
3.610200E-04 |
| Normal-vs-Stage4 |
7.413900E-04 |
| Stage1-vs-Stage2 |
7.394300E-02 |
| Stage1-vs-Stage3 |
5.949800E-01 |
| Stage1-vs-Stage4 |
5.270800E-01 |
| Stage2-vs-Stage3 |
4.911900E-02 |
| Stage2-vs-Stage4 |
4.579600E-02 |
| Stage3-vs-Stage4 |
8.851200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.016840E-04 |
| Normal-vs-AfricanAmerican |
6.654000E-02 |
| Normal-vs-Asian |
4.564700E-03 |
| Caucasian-vs-AfricanAmerican |
6.251600E-01 |
| Caucasian-vs-Asian |
9.678800E-01 |
| AfricanAmerican-vs-Asian |
6.941000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.025500E-04 |
| Normal-vs-Female |
9.862500E-03 |
| Male-vs-Female |
1.004790E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.977600E-04 |
| Normal-vs-Age(41-60Yrs) |
5.357400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.108000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.551100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.316400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.489600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.294420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.181800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.908400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.469700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.846000E-01 |
| Classical-VS-Follicular |
2.027800E-01 |
| Classical-VS-Other |
2.088600E-01 |
| Classical-VS-Normal |
1.602680E-03 |
| Tall-VS-Follicular |
2.687600E-01 |
| Tall-VS-Other |
7.510300E-02 |
| Tall-VS-Normal |
5.922500E-03 |
| Follicular-VS-Other |
3.095700E-02 |
| Follicular-VS-Normal |
2.228400E-01 |
| Other-VS-Normal |
7.264500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.261100E-03 |
| Normal-vs-N1 |
1.302200E-03 |
| N0-vs-N1 |
3.765600E-01 |
|
|
